Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

The Photosensitizer Verteporfin Exerted Anti-Tumor Effect in Diffuse Large B-Cell Lymphoma via Disrupting Yap-Tead Complex

Hematological Oncology

English

High Rate of Morbid Central Line Associated Complications During Treatment With Dose-Adjusted R-Epoch Therapy for Non-Hodgkin Lymphoma

Hematological Oncology

English

POTENTIAL THERAPEUTIC ADVANTAGE FOR DUVELISIB IN MANTLE CELL LYMPHOMA: PI3Kδ AND OVEREXPRESSED PI3Kγ IN LYMPHOMA CELLS HAVE SPECIALIZED FUNCTIONAL ROLES

Hematological Oncology

English

Metabolic Heterogeneity of Baseline 18-FDG Pet-Ct Scan Predicts Outcome in Primary Mediastinal B-Cell Lymphoma.

Hematological Oncology

English

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Exerts Immunomodulatory Activity Towards Tumor-Infiltrating Macrophages

Hematological Oncology

English

Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up

Hematological Oncology

English

Targeting the Peripheral T-Cell Lymphoma (Ptcl) Epigenome With Oral 5-Azacytidine and Romidepsin: Results and Clinical-Molecular Correlations From a Phase 2 Study

Hematological Oncology

English

Primary Central Nervous System Lymphoma: A Curable Disease

Hematological Oncology

English

A Phase 1b/2 Study of Oral Nanatinostat (N) and Valganciclovir (Vg) in Subjects With Epstein-Barr Virus (Ebv)-Associated Lymphomas

Hematological Oncology

English

Validation of the CNS International Prognostic Index in a Large Asian Cohort-Data From the Singapore Lymphoma Study Group

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

The Photosensitizer Verteporfin Exerted Anti-Tumor Effect in Diffuse Large B-Cell Lymphoma via Disrupting Yap-Tead Complex

High Rate of Morbid Central Line Associated Complications During Treatment With Dose-Adjusted R-Epoch Therapy for Non-Hodgkin Lymphoma

POTENTIAL THERAPEUTIC ADVANTAGE FOR DUVELISIB IN MANTLE CELL LYMPHOMA: PI3Kδ AND OVEREXPRESSED PI3Kγ IN LYMPHOMA CELLS HAVE SPECIALIZED FUNCTIONAL ROLES

Metabolic Heterogeneity of Baseline 18-FDG Pet-Ct Scan Predicts Outcome in Primary Mediastinal B-Cell Lymphoma.

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Exerts Immunomodulatory Activity Towards Tumor-Infiltrating Macrophages

Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up

Targeting the Peripheral T-Cell Lymphoma (Ptcl) Epigenome With Oral 5-Azacytidine and Romidepsin: Results and Clinical-Molecular Correlations From a Phase 2 Study

Primary Central Nervous System Lymphoma: A Curable Disease

A Phase 1b/2 Study of Oral Nanatinostat (N) and Valganciclovir (Vg) in Subjects With Epstein-Barr Virus (Ebv)-Associated Lymphomas

Validation of the CNS International Prognostic Index in a Large Asian Cohort-Data From the Singapore Lymphoma Study Group